JOUNCE THERAPEUTICS
Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounce’s proprietary product engine is driving this transformational approach, which has the potential to drive significantly more durable responses to treatment, extending and improving patients’ quality of life. Founded by world leaders in immunobiology, cancer biology and clinical and translational medicine, Jounce Therapeutics was launched in 2013 with funding from leading life sciences investor, Third Rock Ventures.
JOUNCE THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.jouncetx.com
Total Employee:
101+
Status:
Active
Contact:
617-585-2000
Total Funding:
194.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Rani Therapeutics
Rani Therapeutics develops bio-therapeutics technology for the oral delivery of large drug molecules.
Resolve Therapeutics
Resolve Therapeutics is focused on developing a novel approach to the treatment of Systemic Lupus Erythematosus (SLE).
Rodeo Therapeutics
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
Resonant Therapeutics
Resonant Therapeutics is a scalable tumor microenvironment platform that speeds up therapeutic & goal discovery.
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Nivien Therapeutics
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.
Nimble Therapeutics
Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.
Veralox Therapeutics
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
Verseon
Verseon’s breakthroughs in computational chemistry, AI, & synthesis create novel pharmaceuticals. Atom by atom, we drive innovation.
Verseau Therapeutics
Verseau focus is building a pipeline of first-in-class therapies that modulate macrophages to trigger a coordinated immune attack on cancer.
Ventus Therapeutics
Ventus Therapeutics develops small molecule medicines that target innate immune protein structures.
VasoRx
VasoRx is developing RNA therapies for diseases of the cardiovascular system & oncology such as atherosclerosis and pulmonary hypertension.
Memgen
Memgen is a clinical stage biotech developing cancer immunotherapies to harness the power of the immune system to cure cancer
Modus Therapeutics
Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.
MyoScience
MyoScience develops and commercializes technology-driven dermatological products.
Lassen Therapeutics
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
Aqualung Therapeutics
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
Actuate Therapeutics
Actuate Therapeutics provides advancing research to treatment of high impact cancers and neurodegenerative diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aligos Therapeutics
Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Alcyone Therapeutics
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities
APIM Therapeutics
APIM Therapeutics is developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen).
Adagio Therapeutics
Adagio Therapeutics offers research and development of therapeutic pharmaceuticals related to COVID-19.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Allena Pharmaceuticals
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals is a drug development company dedicated to clinically proving the neuroprotective benefits.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Altor BioScience
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
BeneVir Biopharm
Maryland startup BeneVir is developing immunotherapy viruses that rid the body of two types of tumor cells.
Bioject Medical Technologies
Bioject Medical Technologies develops needle-free injection therapies to improve the administration of liquid medications such as vaccines.
Faraday Pharmaceuticals
Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.
7 Hills Pharma
7 Hills Pharma is developing novel immunotherapies for the treatment Of cancer.
TxCell
TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.
TYME
TYME is an emerging biotech developing cancer therapeutics intended to be broadly effective across tumor types with low toxicity profiles.
Tau Therapeutics
Tau Therapeutics engages in the R&D, repositioning and commercialization of calcium T-channel therapies for oncology and other diseases.
Taiga Biotechnologies
Taiga Biotechnologies is a clinical-stage company focused on harnessing the immune system to fight infectious disease and cancer.
Janux Therapeutics
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Annovis Bio
Annovis Bio develops novel treatments for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.
Kineta
Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.
Kodikaz Therapeutic Solutions
Kodikaz is a gene therapy platform company that has the unique technical ability of specifically targeting cancer cells.
Walking Fish Therapeutics
Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.
Wugen
Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Sequoia Sciences
Sequoia Sciences is a pharmaceutical company discovering and developing new medicines for the treatment of bacterial infections and cancers.
SyntheX
SyntheX is a biotechnology firm developing highly specific drugs for previously undruggable targets to treat cancer and rare diseases.
Dignify Therapeutics
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
HDT Bio
IMMUNE THERAPY FOR ALL: We’re transforming inventive immunotherapies for oncology and infectious disease.
Heptares Therapeutics
Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).
Immune Pharmaceuticals
Immune Pharmaceuticals applies a personalized approach to treatment and developing novel antibody therapeutics.
Iconic Therapeutics
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
IRX Therapeutics
IRX Therapeutics develops immune therapies designed to activate a patient’s immune system to defeat cancer and related diseases.
Imcyse
Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.
INmuneBIO
INmune Bio is developing therapies that harness the patient’s immune system to treat cancer.
GenEdit
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
GITR
GITR develops therapies to enhance the immune system by enabling T cells to be more effective in attacking cancer cells.
GO Therapeutics
A new generation of cancer immunotherapy promise to change the paradigm of cancer treatment.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
G-CON Manufacturing
G-CON Manufacturing designs, produces, and installs prefabricated cleanrooms called PODs.
Coferon
Coferon employs bioorthogonal linker chemistry to deliver therapeutic molecules in component parts that self assembles inside target cells.
CytunePharma
Cytune’s goal is to turn novel concepts into best-in class immunotherapeutics restoring and activating the immune system to fight cancer.
Carmine Therapeutics
Carmine Therapeutics is developing novel types of gene therapies that utilize extracellular vesicles (EVs) produced in the laboratory.
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Cybrexa Therapeutics
Cybrexa Therapeutics is a cancer therapeutics company developing a new class of small molecule DNA repair.
Cour Pharmaceuticals Development
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
Prelude Therapeutics
Prelude Therapeutics is a developer of novel therapies intended to target key drivers of cancer cell growth, survival and resistance.
Pear Therapeutics
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
Porton Advanced Solutions
Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
PRISM BioLab
PRISM develop therapeutic drugs that cure these intractable diseases using our unique peptide mimic technology.
ProTom International
ProTom International is a leading device manufacturer of proton therapy technology.
Pulmatrix
Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Casdin Capital
Casdin Capital investment in Series B - Jounce Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Jounce Therapeutics
Omega Funds
Omega Funds investment in Series B - Jounce Therapeutics
Wellington Management
Wellington Management investment in Series B - Jounce Therapeutics
Nextech Invest
Nextech Invest investment in Series B - Jounce Therapeutics
Redmile Group
Redmile Group investment in Series B - Jounce Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Jounce Therapeutics
Inbio Ventures
Inbio Ventures investment in Series B - Jounce Therapeutics
Pharmstandard
Pharmstandard investment in Series B - Jounce Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series A - Jounce Therapeutics
Official Site Inspections
http://www.jouncetx.com Semrush global rank: 3.34 M Semrush visits lastest month: 4.78 K
- Host name: 172.67.136.184
- IP address: 172.67.136.184
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
